| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
COO and CFO | COO, CFO and Secretary | COO, CFO and Secretary +1 more
2 companies
York Charles N II is a COO and CFO at DAWN, with reported holdings spanning 2 companies. Recent filings cover 6 purchases and 31 sales. Those positions are worth an estimated $2.8M at current prices.
Our model assigns York Charles N II a strong insider score of 76/100, based on 29 past trades. Over a 12-month horizon, 88.5% of those trades were profitable, with an average 12-month return of +33.0%.
York Charles N II's largest disclosed position is in DAWN as COO and CFO, worth about $2.6M. The recent filings there lean toward selling, a net 178,711 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO and Secretary | Sale+OE | 922 | $13.86 | $12,778.92 | -0.3% | -12.4% | +1.0% | |
| May 16, 2023 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO and Secretary | Sale+OE | 955 | $13.12 | $12,531.80 | -0.4% | +3.1% | +25.6% | |
| Feb 17, 2023 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO and Secretary | Sell | 9,377 | $20.03 | $187,790.37 | -3.5% | -34.8% | -23.5% | |
| Feb 16, 2023 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO and Secretary | Sale+OE | 930 | $19.57 | $18,202.89 | -0.3% | -32.5% | -21.6% | |
| Jan 20, 2023 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO and Secretary | Sell | 10,000 | $22.75 | $227,523.00 | -3.6% | -42.1% | -38.1% | |
| Dec 20, 2022 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO and Secretary | Sell | 10,000 | $20.07 | $200,650.00 | -3.5% | -10.0% | -32.1% | |
| Nov 21, 2022 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO and Secretary | Sell | 10,000 | $20.76 | $207,569.78 | -3.4% | -5.9% | -41.6% | |
| Nov 16, 2022 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO and Secretary | Sale+OE | 430 | $21.46 | $9,227.71 | -0.1% | -6.0% | -44.7% | |
| Nov 1, 2022 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO and Secretary | Sell | 10,000 | $20.03 | $200,313.00 | -3.3% | +5.5% | -41.4% | |
| Oct 3, 2022 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO and Secretary | Sell | 10,000 | $20.05 | $200,473.00 | -3.2% | +0.9% | -41.4% |